CNMD - Conmed Corp.
Close
73.22
-0.740 -1.011%
Share volume: 410,616
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$73.96
-0.74
-1.00%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-27 | 2023-02-21 | 2023-04-27 | 2023-07-27 | 2023-10-26 | 2024-02-28 | 2024-04-25 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 2.292 B | 2.298 B | 2.320 B | 2.323 B | 2.326 B | 2.300 B | 2.309 B | 2.286 B | |
| Current Assets | 574.243 M | 581.226 M | 610.088 M | 615.522 M | 625.649 M | 615.649 M | 635.724 M | 623.833 M | |
| Inventories | 304.813 M | 332.320 M | 335.370 M | 327.309 M | 325.824 M | 318.324 M | 322.298 M | 322.357 M | |
| Other Current Assets | 38.789 M | 28.619 M | 35.042 M | 31.109 M | 39.127 M | 30.750 M | 38.110 M | 33.385 M | |
| Short Term Investments | 38.789 M | 28.619 M | 35.042 M | 31.109 M | 39.127 M | 30.750 M | 38.110 M | 33.385 M | |
| Total Receivables | 197.287 M | 191.345 M | 213.182 M | 229.256 M | 230.196 M | 242.279 M | 241.461 M | 239.222 M | |
| Current Cash | 33.354 M | 28.942 M | 26.494 M | 27.848 M | 30.502 M | 24.296 M | 33.855 M | 28.869 M | |
| Total Non-current Assets | 1.718 B | 1.716 B | 1.710 B | 1.707 B | 1.700 B | 1.684 B | 1.674 B | 1.662 B | |
| Property Plant Equipment | 113.720 M | 115.611 M | 115.356 M | 116.788 M | 120.436 M | 120.722 M | 117.951 M | 117.089 M | |
| Other Assets | 100.368 M | 93.877 M | 105.639 M | 109.194 M | 107.094 M | 96.111 M | 107.994 M | 105.249 M | |
| Intangible Assets | 689.453 M | 681.799 M | 673.538 M | 665.584 M | 657.353 M | 649.484 M | 641.310 M | 633.244 M | |
| Goodwill | 814.260 M | 815.429 M | 815.499 M | 815.634 M | 815.143 M | 806.844 M | 806.276 M | 806.201 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.292 B | 2.298 B | 2.320 B | 2.323 B | 2.326 B | 2.300 B | 2.309 B | 2.286 B | |
| Total liabilities | 1.576 B | 1.552 B | 1.568 B | 1.543 B | 1.529 B | 1.466 B | 1.455 B | 1.404 B | |
| Total current liabilities | 208.579 M | 296.552 M | 320.686 M | 353.169 M | 376.319 M | 310.729 M | 291.404 M | 266.412 M | |
| Accounts Payable | 74.228 M | 73.393 M | 76.680 M | 78.577 M | 81.871 M | 88.224 M | 101.635 M | 101.286 M | |
| Other liabilities | 218.112 M | 203.694 M | 186.159 M | 151.803 M | 144.072 M | 121.028 M | 109.075 M | 107.254 M | |
| Current long term debt | 237.000 K | 69.746 M | 69.693 M | 69.632 M | 70.625 M | 708.000 K | 692.000 K | 716.000 K | |
| Long term debt | 1.036 B | 985.076 M | 995.276 M | 971.475 M | 942.166 M | 973.140 M | 990.110 M | 965.174 M | |
| Other liabilities | 218.112 M | 203.694 M | 186.159 M | 151.803 M | 144.072 M | 121.028 M | 109.075 M | 107.254 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 716.337 M | 745.545 M | 752.453 M | 780.194 M | 796.205 M | 834.222 M | 854.664 M | 881.832 M | |
| Common stock | 30.473 M | 30.484 M | 30.511 M | 30.662 M | 30.741 M | 30.758 M | 30.780 M | 30.813 M | |
| Retained earnings | 392.144 M | 412.631 M | 408.337 M | 415.924 M | 425.612 M | 452.531 M | 466.082 M | 489.895 M |